AstraZeneca

AstraZeneca is a global biopharmaceutical company that discovers, develops, and commercializes prescription medicines. Its portfolio spans several therapeutic areas, including oncology, cardiovascular, renal and metabolism, respiratory and immunology, infection, and neuroscience. The company also engages in vaccine research and production, most notably the COVID‑19 vaccine developed in partnership with the University of Oxford. AstraZeneca’s products are distributed to patients in markets around the world, serving both developed and emerging economies.

The organization maintains its headquarters in the United Kingdom and operates through a network of offices, research centers, and manufacturing facilities across multiple continents. It conducts research and development activities in sites located in Europe, North America, and Asia, supporting a broad pipeline of drug candidates. AstraZeneca collaborates with hospitals, academic institutions, and contract research organizations to advance clinical trials and regulatory submissions. Its global footprint enables the supply of medicines to diverse populations and health‑care systems.

AstraZeneca is recognized for its strong emphasis on innovative science, investing heavily in both small‑molecule drugs and biologics. The company maintains a deep pipeline of oncology candidates, reflecting its longstanding focus on cancer therapeutics. In addition to its scientific pursuits, AstraZeneca has been the target of sophisticated cyber‑espionage attempts, including a 2020 campaign where North Korea‑linked actors used social engineering to deliver malicious documents to employees involved in pandemic research. These incidents highlight the organization’s visibility in the global health sector and the associated security challenges it faces.

AstraZeneca is a publicly traded public limited company, with its shares listed on the London Stock Exchange under the ticker AZN and on NASDAQ in the United States. The firm’s ownership is dispersed among institutional and individual investors worldwide. It operates through a series of subsidiaries and affiliates that handle regional commercialization, manufacturing, and regulatory affairs. This corporate structure supports its ability to navigate varied legal environments and deliver medicines across international markets.